Unlock stock picks and a broker-level newsfeed that powers Wall Street.
20 Countries With Highest Rates of Cancer

In this article, we’ll take a detailed look at the 20 countries with the highest rates of cancer. For a quick overview of the top five countries, read our article 5 Countries With Highest Rates of Cancer.

Cancer, a pervasive and devastating disease, leaves a profound global impact. Also known as malignant tumors or neoplasms, cancer encompasses a wide array of illnesses that can emerge in various parts of the body. One of its defining features is the rapid growth of abnormal cells that surpass their normal limits, infiltrating nearby tissues and possibly metastasizing to other organs. The World Health Organization (WHO) reports that cancer remains a leading cause of death worldwide, responsible for nearly 10 million deaths in 2020, accounting for almost one in six deaths globally. In addition, the World Cancer Research Fund estimates that 18,094,716 million cases of cancer were diagnosed that same year. When considering all cancers (excluding non-melanoma skin cancer) and combining data for both men and women, the age-standardized rate was 190 cases per 100,000 individuals. Notably, this rate was higher among men, with 206.9 cases per 100,000, compared to women, who had a rate of 178.1 cases per 100,000 individuals. In the global context, Europeans are disproportionately affected by cancer. While Europeans make up only one-tenth of the world population, about 25% of all annual cancer cases occur in Europe.

The field of oncology represents a vast and swiftly expanding domain within biopharmaceutical research and development (R&D). According to Precedence Research, the global oncology market surpassed an impressive value of $203 billion in 2022, and it is estimated to continue growing with a compound annual growth rate (CAGR) of 8.8% until 2032, reaching a significant value of $470.61 billion. Notably, within this growth trajectory, the hospital segment is projected to experience even more rapid expansion, with a forecasted CAGR of 10.9% during the specified period.

See also: 25 Best Hospitals for Cancer Treatment in the World

On the other hand, the field of cancer vaccines has also gained significant global attention. Cancer treatment vaccines differ from the vaccines designed to combat viruses. The primary goal of cancer treatment vaccines is to stimulate the immune system to target and attack cancer cells present within the body. Unlike preventive vaccines that aim to stop diseases from occurring, cancer treatment vaccines are intended to trigger an immune response against an existing disease, encouraging the immune system to combat and potentially eradicate cancerous cells. Merck & Co., Inc. (NYSE:MRK) and Moderna, Inc. (NASDAQ:MRNA) have joined forces to develop a promising vaccine, combining an mRNA cancer vaccine with Moderna's Keytruda®. On July 26, the companies announced that the enrollment of patients had commenced for a late-stage clinical trial. Promising results from a mid-stage study involving 157 patients revealed that the combination of the vaccine and Keytruda significantly reduced the risk of recurrence or death by 44% in individuals with melanoma, the most fatal type of skin cancer, compared to the use of Keytruda alone. The progress in these areas showcases the increasing promise and dedication to enhancing cancer treatment using innovative vaccine strategies. If you're interested in learning more information about companies engaged in oncology and vaccine development, our list of the 11 Most Promising Cancer Stocks According to Analysts provides valuable insights.